NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 68084-0155-01 — Promethazine 25 mg tabletsAI (503 hospitals, 27,427–28,588 samples)
• NDC 00904-6322-61 — Metoprolol succinate 25 mg extended-release tabletAI (622 hospitals, 27,948–28,587 samples)
• NDC 61553-0320-70 — Ketamine 50 mg/5 mL prefilled syringeAI (68 hospitals, 28,388–28,577 samples)
• NDC 00406-9175-76 — Fentanyl 75 mcg/hr transdermal patchAI (276 hospitals, 27,883–28,576 samples)
• NDC 60505-1005-01 — Timolol eye drops, 0.5%, 5 mL bottleAI (140 hospitals, 27,883–28,576 samples)
• NDC 75834-0147-06 — Hydrocortisone 25 mg rectal suppositoryAI (66 hospitals, 27,883–28,576 samples)
• NDC 75834-0147-12 — Hydrocortisone 25 mg rectal suppositoryAI (174 hospitals, 27,883–28,576 samples)
• NDC 00781-7119-58 — Estradiol weekly transdermal patchAI (53 hospitals, 27,883–28,576 samples)
• NDC 64980-0513-15 — Timolol eye drops 0.25%AI (34 hospitals, 27,883–28,576 samples)
• NDC 00378-3361-16 — Estradiol weekly transdermal patchAI (21 hospitals, 27,883–28,576 samples)
• NDC 00065-0816-04 — OLOPATADINE 0.7 % EYE DROPSAI (27 hospitals, 27,883–28,576 samples)
• NDC 62584-0994-01 — Warfarin 5 mg tabletsAI (529 hospitals, 27,882–28,575 samples)
• NDC 00172-5728-60 — famotidine 20 mg tabletAI (425 hospitals, 27,902–28,568 samples)
• NDC 49471-0001-01 — Benzylpenicilloyl polylysine skin test solutionAI (81 hospitals, 27,850–28,552 samples)
• NDC 00904-7177-61 — Furosemide 20 mg tabletsAI (685 hospitals, 27,647–28,547 samples)
• NDC 52817-0816-15 — Acetic acid 2% ear dropsAI (424 hospitals, 27,523–28,531 samples)
• NDC 00409-4887-20 — Sterile water for injectionAI (439 hospitals, 27,907–28,528 samples)
• NDC 68180-0295-06 — Duloxetine 30 mg delayed-release capsuleAI (368 hospitals, 27,909–28,521 samples)
• NDC 60505-4642-03 — Prasugrel 5 mg tabletsAI (499 hospitals, 27,907–28,501 samples)
• NDC 33342-0333-15 — Triamcinolone acetonide 0.1% ointmentAI (385 hospitals, 27,474–28,491 samples)
• NDC 51079-0453-20 — Midodrine hydrochloride 5 mg tabletsAI (492 hospitals, 27,887–28,490 samples)
• NDC 60687-0491-01 — Naproxen 500 mg tabletsAI (307 hospitals, 27,887–28,490 samples)
• NDC 72162-1389-02 — Estradiol vaginal creamAI (53 hospitals, 27,593–28,484 samples)
• NDC 60687-0638-01 — LORAZEPAM 1 MG TABLETAI (194 hospitals, 27,886–28,480 samples)
• NDC 63323-0723-06 — Remifentanil intravenous solutionAI (92 hospitals, 27,873–28,476 samples)
• NDC 63323-0725-10 — REMIFENTANIL 5 MG INTRAVENOUS SOLUTIONAI (98 hospitals, 27,873–28,476 samples)
• NDC 63304-0692-01 — Clindamycin 150 mg capsulesAI (432 hospitals, 27,783–28,476 samples)
• NDC 00406-0512-01 — Oxycodone and acetaminophen 5 mg/325 mg tabletAI (296 hospitals, 27,828–28,476 samples)
• NDC 09991-3261-00 — Zinc sulfate intravenous solutionAI (17 hospitals, 27,873–28,476 samples)
• NDC 65862-0677-01 — ALPRAZolam 0.5 mg tabletAI (466 hospitals, 27,885–28,470 samples)
• NDC 83851-0100-30 — Fluorescein eye test stripsAI (243 hospitals, 27,214–28,465 samples)
• NDC 50242-0100-40 — Pulmozyme 2.5 mg/2.5 mL inhalation solutionAI (1047 hospitals, 28,428–28,464 samples)
• NDC 00185-5050-01 — metOLazone 2.5 mg tabletAI (500 hospitals, 27,838–28,459 samples)
• NDC 70092-1400-43 — Fentanyl injection syringe, 10 mcg per mLAI (191 hospitals, 26,992–28,459 samples)
• NDC 50419-0325-13 — Gadavist contrast injection for imagingAI (405 hospitals, 24,935–28,454 samples)
• NDC 72205-0042-11 — Oseltamivir 30 mg capsulesAI (432 hospitals, 27,883–28,450 samples)
• NDC 51079-0771-20 — Carvedilol 3.125 mg oral tabletsAI (340 hospitals, 27,883–28,450 samples)
• NDC 00407-1414-76 — Iohexol 350 contrast dye for intravenous injectionAI (69 hospitals, 27,546–28,446 samples)
• NDC 66689-0020-50 — Megestrol acetate oral suspensionAI (162 hospitals, 27,882–28,440 samples)
• NDC 00409-1109-01 — Atracurium injection, muscle relaxant for surgeryAI (123 hospitals, 28,345–28,435 samples)
• NDC 00264-7652-00 — Potassium chloride in dextrose and saline IV solutionAI (526 hospitals, 26,552–28,433 samples)
• NDC 51991-0983-99 — Norepinephrine intravenous solution 1 mg/mLAI (104 hospitals, 28,373–28,427 samples)
• NDC 17478-0937-25 — dilTIAZem 5 mg/mL intravenous solutionAI (271 hospitals, 28,010–28,424 samples)
• NDC 00641-6014-10 — Diltiazem hydrochloride 50 mg/10 mL intravenous solutionAI (411 hospitals, 28,010–28,424 samples)
• NDC 00904-6474-61 — Pantoprazole 40 mg tabletAI (506 hospitals, 27,848–28,424 samples)
• NDC 00009-0323-01 — Absorbable gelatin spongeAI (131 hospitals, 28,342–28,405 samples)
• NDC 63323-0886-01 — Sodium phosphate oral solutionAI (119 hospitals, 26,203–28,390 samples)
• NDC 44206-0310-90 — Albumin 5% intravenous solutionAI (319 hospitals, 27,995–28,382 samples)
• NDC 63323-0491-57 — Xylocaine 0.5% injectable numbing medicine, preservative-freeAI (703 hospitals, 25,639–28,375 samples)
• NDC 68084-0709-01 — Venlafaxine extended-release 75 mg capsuleAI (627 hospitals, 27,618–28,374 samples)